Achieve Life Sciences, Inc.
1040 West Georgia Street
Suite 1030
Vancouver, BC V6E 4H1
Canada
604-210-2217
https://www.achievelifesciences.com
版塊: Healthcare
行業: Biotechnology
全職員工: 22
高階主管
| 名稱 | 頭銜 | 支付 | 行使價 | 出生年份 |
|---|---|---|---|---|
| Dr. Richard A. B. Stewart | Executive Chairman | 663.75k | 無 | 1959 |
| Mr. John A. Bencich M.B.A. | CEO & Director | 781.75k | 無 | 1977 |
| Dr. Cindy Jacobs M.D., Ph.D. | President, Chief Medical Officer & Director | 652.74k | 無 | 1958 |
| Mr. Jerry Wan | Principal Accounting Officer | 無 | 無 | 1982 |
| Dr. Anthony Clarke Ph.D. | Chief Scientific Officer | 546k | 無 | 1956 |
| Ms. Jaime Xinos | Executive Vice President of Commercial | 無 | 無 | 無 |
截止 2023年12月31日為止計算的金額，現金賠償則計算至上一個財政年度末止。薪資是指薪俸、獎金等。已行使價是指財政年度期間已行使的期權價值。貨幣為 USD。
描述
Achieve Life Sciences, Inc., a clinical-stage pharmaceutical company, develops and commercializes cytisinicline for smoking cessation and nicotine addiction. The company offers cytisinicline, a plant-based alkaloid that interacts with nicotine receptors in the brain that reduce the severity of nicotine withdrawal symptoms. It has license and supply agreement with Sopharma AD and University of Bristol Achieve Life Sciences, Inc. is based in Vancouver, Canada.
公司管治
截至 無 止，Achieve Life Sciences, Inc. 的 ISS 管治質素評分為 無。 Pillar 分數正在審核中：無；董事會：無；股東權利：無；現金賠償：無。
企業管治評分的資料提供： Institutional Shareholder Services (ISS). 評分將以 1 至 10 分顯示 (與指數或地區相關)。1 分表示較低的管治風險，而 10 分表示較高的管治風險。
